NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  



NIH Main


NIH Research News


Funded News

  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
  Additional Resources
  NIH Home Page

About NIH

  NIH Health Information
  Pub Med
  More News and Events Sources
  NIH News and Events, Special Interest
  RSS Feed RSS Feed
  Back to EurekAlert!


Department of Health and Human Services

News from the National Institutes of Health

Funded News

Key: Meeting M      Journal J      Funder F

Showing releases 3151-3175 out of 3499.

<< < 122 | 123 | 124 | 125 | 126 | 127 | 128 | 129 | 130 | 131 > >>

Public Release: 28-Nov-2013
High cholesterol fuels the growth and spread of breast cancer
A byproduct of cholesterol functions like the hormone estrogen to fuel the growth and spread of the most common types of breast cancers, researchers at the Duke Cancer Institute report.
National Institutes of Health

Contact: Sarah Avery
Duke University Medical Center

Public Release: 27-Nov-2013
Analytical and Bioanalytical Chemistry
Sorting good germs from bad, in the bacterial world
There are good E. coli and bad E. coli. Some live in your gut and help you keep healthy, others can cause serious disease -- even death. For pathologists, telling them apart has been a long and laborious task sometimes taking days. New technology, developed in the lab of Mark Hayes at Arizona State University, using microscale electric field gradients now can tell the difference between good and bad bacteria in minutes from extremely small samples.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jenny Green
Arizona State University

Public Release: 27-Nov-2013
Perspectives on Psychological Science
Study of young parents highlights links among stress, poverty and ethnicity
An avalanche of chronic stress affecting poor mothers and fathers is revealed in new data from a comprehensive national, federally funded study.
NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development

Contact: Stuart Wolpert
University of California - Los Angeles

Public Release: 27-Nov-2013
Nature Cell Biology
MD Anderson researchers identify a rescuer for vital tumor-suppressor
The tumor-suppessing protein PTEN is absent in many cancers, yet defects in the PTEN gene do not account for this disappearance. MD Anderson researchers identified an enzyme that keep PTEN from being fed to the cell's protein-recycling mechanism.
NIH/National Cancer Institute, Cancer Prevention and Research Institute of Texas

Contact: Scott Merville
University of Texas M. D. Anderson Cancer Center

Public Release: 27-Nov-2013
Circadian timing may give edge to West Coast NFL teams in night games
A new analysis of National Football League results suggests that the body's natural circadian timing gives a performance advantage to West Coast teams when they play East Coast teams at night.
National Institutes of Health, National Science Foundation

Contact: Lynn Celmer
American Academy of Sleep Medicine

Public Release: 27-Nov-2013
Scientists work to engineer an injectable therapy for rotator cuff injuries
A research team at Georgia Tech is attempting to engineer an injectable therapy for the shoulder's supraspinatus tendon, a rotator cuff tendon that is commonly torn in sports. When the tendon is damaged, the body makes things worse by activating enzymes that further break down the tendon. The scientists hope to develop an injectable compound that would deliver an inhibitor capable of blocking these enzymes, thereby reducing the severity of the injury or even healing the tissue.
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases

Contact: Brett Israel
Georgia Institute of Technology

Public Release: 27-Nov-2013
Science Translational Medicine
Pills of the future: Nanoparticles
Researchers at MIT and BWH design drug-carrying nanoparticles that can be taken orally instead of being injected.
Koch-Prostate Cancer Foundation Award in Nanotherapeutics, NIH/National Cancer Institute Center of Cancer Nanotechnology Excellence, NIH/National Heart, Lung, and Blood Institute Program of Excellence in Nanotechnology Award, and others

Contact: Sarah McDonnell
Massachusetts Institute of Technology

Public Release: 27-Nov-2013
Cancer Epidemiology, Biomarkers & Prevention
Negative BRCA testing may not always imply lowered breast cancer risk
Women who are members of families with BRCA2 mutations but who test negative for the family-specific BRCA2 mutations are still at greater risk for developing breast cancer compared with women in the general population, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
NIH/National Institute for Health Research

Contact: Jeremy Moore
American Association for Cancer Research

Public Release: 27-Nov-2013
Science Translational Medicine
Scientists develop way to successfully give nanoparticle therapeutics orally
Researchers at Brigham and Women's Hospital and Massachusetts Institute of Technology are the first to report in the field of nanomedicine a new type of nanoparticle that can be successfully absorbed through the digestive tract.
National Institutes of Health

Contact: Marjorie Montemayor-Quellenberg
Brigham and Women's Hospital

Public Release: 27-Nov-2013
Science Translational Medicine
Clinical trial shows tongue-controlled wheelchair outperforms popular wheelchair navigation system
Individuals with paralysis in a new clinical trial were able to use a tongue-controlled technology to access computers and execute commands for their wheelchairs at speeds that were significantly faster than those recorded in sip-and-puff wheelchairs, but with equal accuracy. The new study is the first to show that the wireless and wearable Tongue Drive System outperforms sip-and-puff in controlling wheelchairs. Sip-and-puff is the most popular assistive technology for controlling a wheelchair.
NIH/National Institute of Biomedical Imaging and Bioengineering, National Science Foundation

Contact: Brett Israel
Georgia Institute of Technology

Public Release: 27-Nov-2013
Genetic mutation increases risk of Parkinson's disease from pesticides
A study uses patient-derived stem cells to show that a mutation in the alpha-synuclein gene causes increased vulnerability to pesticides, leading to Parkinson's disease.
National Institutes of Health

Contact: Susan Gammon, Ph.D.
Sanford-Burnham Medical Research Institute

Public Release: 27-Nov-2013
New England Journal of Medicine
Pitt unlocks trove of public health data to help fight deadly contagious diseases
In an unprecedented windfall for public access to health data, University of Pittsburgh Graduate School of Public Health researchers have digitized all weekly surveillance reports for reportable diseases in the US going back 125 years. The database, described in the New England Journal of Medicine, is free and public. Supported by the Bill & Melinda Gates Foundation and the National Institutes of Health, the project's goal is to aid in the eradication of devastating diseases.
National Institutes of Health, Bill & Melinda Gates Foundation

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Public Release: 26-Nov-2013
Scientists design and test new approach for corneal stem cell treatments
Researchers in the Cedars-Sinai Regenerative Medicine Institute have designed and tested a novel, minute-long procedure to prepare human amniotic membrane for use as a scaffold for specialized stem cells that may be used to treat some corneal diseases. This membrane serves as a foundation that supports the growth of stem cells in order to graft them onto the cornea.
National Institutes of Health, Cedars-Sinai Regenerative Medicine Institute

Contact: Cara Martinez
Cedars-Sinai Medical Center

Public Release: 26-Nov-2013
Developmental Cell
UCLA research may help scientists understand what causes pregnancy complications
Dr. Hanna Mikkola and researchers at UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have identified a specific type of cell and a related cell communication pathway that are key to the successful growth of a healthy placenta. The findings could greatly bolster our knowledge about the potential causes of complications during pregnancy.
National Institutes of Health, UCLA/Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research

Contact: Shaun Mason
University of California - Los Angeles

Public Release: 26-Nov-2013
National study finds donor age not a factor in most corneal transplants
Ten years after a transplant, a cornea from a 71-year-old donor is likely to remain as healthy as a cornea from a donor half that age, and corneas from donors over 71 perform slightly less well but still remain healthy for most transplant recipients, according to a study funded by the National Eye Institute and led by the UC Davis Health System Eye Center and the University of Cincinnati Eye Institute.
NIH/National Eye Institute, Eye Bank Association of America, Bausch & Lomb, Tissue Banks International, Vision Share

Contact: Carole Gan
University of California - Davis Health System

Public Release: 26-Nov-2013
Neurology Clinical Practice
Kessler stroke researchers explore five new avenues for rehabilitation research
Because the concept of permanent neurological injury has given way to recognition of the brain's potential for long-term regeneration ad reorganization, rehabilitations strategies are undergoing radical changes. The potential for five new translational interventions was examined in an article published ahead of print on Nov. 13 by Neurology Clinical Practice. The five treatments are based on behavioral or non-invasive physiological stimulation.
National Institutes of Health, Kessler Foundation

Contact: Carolann Murphy
Kessler Foundation

Public Release: 26-Nov-2013
Genes & Development
Scientists discover how leukemia cells exploit 'enhancer' DNA elements to cause lethal disease
A team of researchers at Cold Spring Harbor Laboratory has identified a leukemia-specific stretch of DNA called an enhancer element that enables cancerous blood cells to proliferate in acute myeloid leukemia, a devastating cancer that is incurable in 70 percent of patients. Just as important, the findings offer a mechanistic insight into how a new class of promising drugs -- one version of which is already in human clinical trials -- appears to halt the growth of cancer cells so effectively.
National Institutes of Health

Contact: Jaclyn Jansen
Cold Spring Harbor Laboratory

Public Release: 26-Nov-2013
Journal of Neuroscience
Drug reduces brain changes, motor deficits associated with Huntington's disease
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing Nov. 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins -- the molecules that support the survival and function of nerve cells -- may slow the progression of Huntington's disease and other neurodegenerative disorders.
Taube Philanthropies, Koret Foundation, Jean Perkins Foundation, National Institutes of Health

Contact: Kathleen Snodgrass
Society for Neuroscience

Public Release: 26-Nov-2013
Journal of the Association of Nurses in AIDS Care
Women living with HIV share their stories through photography
A University of Missouri researcher found that participating in photovoice, a process by which individuals document their lives by taking pictures, empowered women living with HIV to realize their strengths in the midst of their struggles.
National Institutes of Health

Contact: Jesslyn Chew
University of Missouri-Columbia

Public Release: 26-Nov-2013
Wayne State part of team for license on new ways to manage cancer with green tea extracts
Wayne State University, along with McGill University and the Hong Kong Polytechnic University, have executed an exclusive worldwide license with Viteava Pharmaceutical Inc. for an intellectual property portfolio claiming composition of matter and/or methods of use of novel analogs and derivatives of the green tea flavonoid, (-)epigallocatechin-3-gallate.
NIH/National Cancer Institute

Contact: Julie O'Connor
Wayne State University - Office of the Vice President for Research

Public Release: 26-Nov-2013
RSNA and Regenstrief Institute launch effort to unify radiology procedure naming
Under a contract awarded by the National Institute of Biomedical Imaging and Bioengineering, the developers of two advanced medical terminologies have begun work to harmonize and unify terms for radiology procedures. Creating standardized radiology procedure names will improve the quality, consistency and interoperability of radiology test results in electronic medical record systems and health information exchange.
NIH/National Institute of Biomedical Imaging and Bioengineering

Contact: Cindy Fox Aisen
Indiana University

Public Release: 26-Nov-2013
Cell Stem Cell
Researchers at Penn uncover mechanism behind blood stem cells' longevity
Researchers have long wondered what allows blood stem cells to persist for decades, when their progeny last for days, weeks or months before they need to be replaced. Now, a study from the University of Pennsylvania has uncovered one of the mechanisms that allow these stem cells to keep dividing in perpetuity.
National Institutes of Health, Human Frontier Science Program, American Heart Association

Contact: Evan Lerner
University of Pennsylvania

Public Release: 26-Nov-2013
Breast Cancer Research
High-fat diet during puberty speeds up breast cancer development
New findings show that eating a high-fat diet beginning at puberty speeds up the development of breast cancer and may actually increase the risk of cancer similar to a type often found in younger adult women.
NIH/National Institute of Environmental Health, NIH/National Cancer Institute

Contact: Sarina Gleason
Michigan State University

Public Release: 26-Nov-2013
Screening new inmates for HIV may not reveal many new undetected cases, study shows
More than 22,000 inmates entering North Carolina prisons in 2008 and 2009 were tested for HIV, but only 20 previously undiagnosed cases of HIV were found in this population.
NIH/National Institute on Drug Abuse

Contact: Lisa Chensvold
University of North Carolina Health Care

Public Release: 25-Nov-2013
Journal of Adolescent Health
Electronic cigarettes: New route to smoking addiction for adolescents
E-cigarettes have been widely promoted as a way for people to quit smoking conventional cigarettes. Now, in the first study of its kind, UC San Francisco researchers are reporting that, at the point in time they studied, youth using e-cigarettes were more likely to be trying to quit, but also were less likely to have stopped smoking and were smoking more, not less.
NIH/National Cancer Institute, University of California, Tobacco Related Diseases Research Program, Hellmann Family Fund

Contact: Elizabeth Fernandez
University of California - San Francisco

Showing releases 3151-3175 out of 3499.

<< < 122 | 123 | 124 | 125 | 126 | 127 | 128 | 129 | 130 | 131 > >>


Copyright ©2014 by AAAS, the science society.